Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Effect of Lactobacillus sporogenes on oral isoflavones bioavailability: single dose pharmacokinetic study in menopausal women.

Benvenuti C, Setnikar I.

Arzneimittelforschung. 2011;61(11):605-9. doi: 10.1055/s-0031-1300562.

PMID:
22232848
3.

Antiatherosclerotic efficacy of policosanol, red yeast rice extract and astaxanthin in the rabbit.

Setnikar I, Senin P, Rovati LC.

Arzneimittelforschung. 2005;55(6):312-7.

PMID:
16032970
4.

Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot study.

Ringe JD, Dorst A, Faber H, Kipshoven C, Rovati LC, Setnikar I.

Rheumatol Int. 2005 May;25(4):296-300. Epub 2005 Mar 16.

PMID:
15770482
6.

Glucosamine for osteoarthritis. Sound science might have helped avoid confusion.

Setnikar I.

BMJ. 2001 Oct 27;323(7319):1003-4. No abstract available.

PMID:
11700628
7.

Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.

Setnikar I, Rovati LC.

Arzneimittelforschung. 2001 Sep;51(9):699-725. Review.

PMID:
11642003
8.

Correct regimen of fluoride and calcium reduces the risk of vertebral fractures in postmenopausal osteoporosis.

Reginster JY, Rovati LC, Setnikar I.

Osteoporos Int. 2001;12(9):800. No abstract available.

PMID:
11605748
9.

Assessment of skin safety of a new glyceryl trinitrate transdermal patch. Animal and human studies.

Santoro A, Rovati LC, Setnikar I.

Arzneimittelforschung. 2001 Jan;51(1):29-37.

PMID:
11215323
10.

Bioavailability and pharmacokinetic profile of dihydroergotoxine from a tablet and from an oral solution formulation.

Setnikar I, Schmid K, Rovati LC, Vens-Cappell B, Mazur D, Kozak I.

Arzneimittelforschung. 2001 Jan;51(1):2-6.

PMID:
11215321
11.

Pharmaceutical development and characteristics of a new glyceryl trinitrate transdermal patch

Santoro A, Rovati LC, Lanzini R, Setnikar I I.

Arzneimittelforschung. 2000 Oct;50(10):897-903.

PMID:
11105231
13.

Plasma levels of glyceryl trinitrate and dinitrates during application of three strengths of a new glyceryl trinitrate transdermal patch.

Santoro A, Rovati LC, Follet M, Setnikar I, Caplain H, Gualano V.

Arzneimittelforschung. 2000 Sep;50(9):786-94.

PMID:
11050694
14.
15.
16.

Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches. A randomized, double-blind placebo-controlled study.

De Aloysio D, Rovati LC, Giacovelli G, Setnikar I, Bottiglioni F.

Arzneimittelforschung. 2000 Mar;50(3):293-300.

PMID:
10758784
17.
18.

Glucosamine in osteoarthritis.

Rovati LC, Annefeld M, Giacovelli G, Schmid K, Setnikar I.

Lancet. 1999 Nov 6;354(9190):1640; author reply 1641-2. No abstract available.

PMID:
10560693
19.

Estradiol and estrone plasma levels during application of three strengths of a 7-day estradiol transdermal patch.

Setnikar I, Rovati LC, Santoro A, Guillaume M, Mignot A, Renoux A, Gualano V.

Arzneimittelforschung. 1999 Aug;49(8):708-15.

PMID:
10483519
20.

Bioavailability and pharmacokinetic characteristics of two monofluorophosphate preparations with calcium supplement.

Setnikar I, Rovati LC, Schmid K, Vens-Cappell B, Barkworth MF.

Arzneimittelforschung. 1998 Dec;48(12):1172-8.

PMID:
9893933
21.
22.

The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial.

Reginster JY, Meurmans L, Zegels B, Rovati LC, Minne HW, Giacovelli G, Taquet AN, Setnikar I, Collette J, Gosset C.

Ann Intern Med. 1998 Jul 1;129(1):1-8.

PMID:
9652994
23.

Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis.

Qiu GX, Gao SN, Giacovelli G, Rovati L, Setnikar I.

Arzneimittelforschung. 1998 May;48(5):469-74.

PMID:
9638313
24.

Pharmacokinetics of estradiol and of estrone during application of a new 7-day estradiol transdermal patch with active matrix.

Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.

Arzneimittelforschung. 1998 Mar;48(3):275-85.

PMID:
9553686
25.

Pharmacokinetics of estradiol and of estrone during application of three strengths of an estradiol transdermal patch with active matrix.

Setnikar I, Rovati LC, Thebault JJ, Guillaume M, Mignot A, Renoux A, Gualano V.

Arzneimittelforschung. 1997 Jul;47(7):859-65.

PMID:
9272245
26.

Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol.

Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.

Arzneimittelforschung. 1996 Aug;46(8):766-73.

PMID:
9125276
27.

Bioavailability of estradiol from two transdermal patches.

Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.

Arzneimittelforschung. 1996 Mar;46(3):307-10.

PMID:
8901155
28.

Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee.

Müller-Fassbender H, Bach GL, Haase W, Rovati LC, Setnikar I.

Osteoarthritis Cartilage. 1994 Mar;2(1):61-9.

PMID:
11548225
29.

Glucosamine sulfate in osteoarthritis of the knee.

Noack W, Fischer M, Förster KK, Rovati LC, Setnikar I.

Osteoarthritis Cartilage. 1994 Mar;2(1):51-9.

PMID:
11548224
30.

Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomised, placebo-controlled, double-blind study.

Reichelt A, Förster KK, Fischer M, Rovati LC, Setnikar I.

Arzneimittelforschung. 1994 Jan;44(1):75-80.

PMID:
8135881
31.

Pharmacokinetics of glucosamine in man.

Setnikar I, Palumbo R, Canali S, Zanolo G.

Arzneimittelforschung. 1993 Oct;43(10):1109-13.

PMID:
8267678
32.

Effects of meal on the pharmacokinetics of fluoride from oral monofluorophosphate.

Warneke G, Setnikar I.

Arzneimittelforschung. 1993 May;43(5):590-5.

PMID:
8329005
33.

Bioavailability and pharmacokinetics of fluoride from two glutamine monofluorophosphate preparations.

Warneke G, Setnikar I.

Arzneimittelforschung. 1993 May;43(5):584-90.

PMID:
8329004
34.

Sodium fluoride-induced gastric mucosal lesions: comparison with sodium monofluorophosphate.

Müller P, Schmid K, Warnecke G, Setnikar I, Simon B.

Z Gastroenterol. 1992 Apr;30(4):252-4.

PMID:
1604908
35.

Antireactive properties of "chondroprotective" drugs.

Setnikar I.

Int J Tissue React. 1992;14(5):253-61. Review.

PMID:
1300311
36.

Antiarthritic effects of glucosamine sulfate studied in animal models.

Setnikar I, Pacini MA, Revel L.

Arzneimittelforschung. 1991 May;41(5):542-5.

PMID:
1898426
37.

Antireactive properties of glucosamine sulfate.

Setnikar I, Cereda R, Pacini MA, Revel L.

Arzneimittelforschung. 1991 Feb;41(2):157-61.

PMID:
1645969
38.

Bioequivalence of sodium monofluorophosphate with sodium fluoride and compatibility with calcium.

Setnikar I, Maurer H.

Arzneimittelforschung. 1990 Sep;40(9):994-9.

PMID:
2080951
39.

Effect of loxiglumide on gallbladder contractile response to cerulein and food in humans.

Malesci A, De Fazio C, Festorazzi S, Bonato C, Valentini A, Tacconi M, Rovati L, Setnikar I.

Gastroenterology. 1990 May;98(5 Pt 1):1307-10.

PMID:
2323521
40.

Relative bioavailability of fluoride from monofluorophosphate tablets after single oral administration.

Setnikar I, Maurer H.

Arzneimittelforschung. 1990 Mar;40(3):323-8.

PMID:
2346544
41.

Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.

Hildebrand P, Beglinger C, Gyr K, Jansen JB, Rovati LC, Zuercher M, Lamers CB, Setnikar I, Stalder GA.

J Clin Invest. 1990 Mar;85(3):640-6.

42.

Pharmacokinetics and tolerance of repeated oral doses of loxiglumide.

Setnikar I, Chisté R, Giacovelli G, Rovati LC.

Arzneimittelforschung. 1989 Nov;39(11):1454-9.

PMID:
2619779
43.

Pharmacological characterisation of the smooth muscle antispasmodic agent tiropramide.

Setnikar I, Cereda R, Pacini MA, Revel L, Makovec F.

Arzneimittelforschung. 1989 Sep;39(9):1114-9.

PMID:
2590261
44.

Antispasmodic activity of tiropramide.

Setnikar I, Cereda R, Pacini MA, Revel L, Makovec F.

Arzneimittelforschung. 1989 Sep;39(9):1109-14.

PMID:
2590260
45.

Distribution of tiropramide and metabolites after single intravenous or peroral administration of 14C-tiropramide to the rat.

Setnikar I, Makovec F, Chistè R, Giachetti C, Zanolo G.

Arzneimittelforschung. 1989 May;39(5):579-86.

PMID:
2757674
46.

Metabolism and excretion of 14C-tiropramide after single intravenous or peroral administration to the rat.

Setnikar I, Makovec F, Chistè R, Giachetti C, Zanolo G.

Arzneimittelforschung. 1989 Mar;39(3):328-34.

PMID:
2757659
47.

Tiropramide and metabolites in blood and plasma after intravenous or peroral administration of 14C-tiropramide to the rat.

Setnikar I, Makovec F, Chistè R, Giachetti C, Zanolo G.

Arzneimittelforschung. 1988 Dec;38(12):1815-9.

PMID:
3245854
48.

Pharmacokinetics of loxiglumide after single intravenous or oral doses in man.

Setnikar I, Chisté R, Makovec F, Rovati LC, Warrington SJ.

Arzneimittelforschung. 1988 May;38(5):716-20.

PMID:
3415715
49.

Identification of metabolites of tiropramide in human urine.

Arigoni R, Chistè R, Makovec F, Setnikar I, Benfenati E, Fanelli R.

Biomed Environ Mass Spectrom. 1988 Feb 15;15(4):205-9.

PMID:
3370360
50.

Chemical stability and mode of gastrointestinal absorption of sodium monofluorophosphate.

Setnikar I, Arigoni R.

Arzneimittelforschung. 1988 Jan;38(1):45-9.

PMID:
3365276

Supplemental Content

Loading ...
Support Center